UAE Infectious Disease Therapeutics Market Size & Outlook
UAE infectious disease therapeutics market, 2018-2030 (US$M)
Related Markets
UAE infectious disease therapeutics market highlights
- The UAE infectious disease therapeutics market generated a revenue of USD 806.8 million in 2024 and is expected to reach USD 1,014.7 million by 2030.
- The UAE market is expected to grow at a CAGR of 4.9% from 2025 to 2030.
- In terms of segment, viral infections was the largest revenue generating infection type in 2024.
- Parasitic Infections is the most lucrative infection type segment registering the fastest growth during the forecast period.
Infectious disease therapeutics market data book summary
| Market revenue in 2024 | USD 806.8 million |
| Market revenue in 2030 | USD 1,014.7 million |
| Growth rate | 4.9% (CAGR from 2025 to 2030) |
| Largest segment | Viral infections |
| Fastest growing segment | Parasitic Infections |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections |
| Key market players worldwide | Novartis AG ADR, Gilead Sciences Inc, GlaxoSmithKline, Johnson & Johnson, Roche Holding AG ADR, BioCryst Pharmaceuticals Inc, Merck & Co Inc, Boehringer Ingelheim |
Other key industry trends
- In terms of revenue, UAE accounted for 0.3% of the global infectious disease therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa infectious disease therapeutics market is projected to lead the regional market in terms of revenue in 2030.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,919.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Therapeutics Market Scope
Infectious Disease Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE infectious disease therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease therapeutics market will help companies and investors design strategic landscapes.
Viral infections was the largest segment with a revenue share of 40.38% in 2024. Horizon Databook has segmented the UAE infectious disease therapeutics market based on bacterial infections, viral infections, fungal infections, parasitic infections covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to UAE infectious disease therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE infectious disease therapeutics market databook
-
Our clientele includes a mix of infectious disease therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE infectious disease therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into UAE infectious disease therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE infectious disease therapeutics market size, by infection type, 2018-2030 (US$M)
UAE Infectious Disease Therapeutics Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
